Zobrazeno 1 - 10
of 62
pro vyhledávání: '"erythropoietins"'
Autor:
L. Yu. Vladimirova, N. A. Abramova, A. A. Lyanova, A. E. Storozhakova, I. L. Popova, M. A. Teplyakova, N. M. Tikhanovskaya, L. A. Ryadinskaya, E. A. Kalabanova, S. N. Kabanov, I. A. Udalenkova
Publikováno v:
Медицинский совет, Vol 0, Iss 9, Pp 117-125 (2022)
Introduction. Erythropoietin (EPO) application is a pathogenetic method for anemia correction in cancer patients.The purpose of study. Clinical evaluation of the efficacy and safety of Eralfon® (epoetin alpha) in treatment for anemia in patients wit
Externí odkaz:
https://doaj.org/article/0556a280772a4126b0e98abb8dd6c6c2
Autor:
O. A. Vaganova
Publikováno v:
Регуляторные исследования и экспертиза лекарственных средств, Vol 11, Iss 4, Pp 273-275 (2021)
“Glycan Profile” is a necessary part of manufacturers’ product specification files for monoclonal antibody active ingredients or final products and erythropoietin active ingredients. The expert of the Federal State Budgetary Institution “Scie
Externí odkaz:
https://doaj.org/article/a64bd4dc64384b799b27b19ee5a96a9d
Autor:
O. A. Vaganova
Publikováno v:
Регуляторные исследования и экспертиза лекарственных средств, Vol 11, Iss 4, Pp 276-277 (2021)
‘Identification. Peptide mapping’ is a necessary part of manufacturers’ product specification files for therapeutic proteins (active ingredients and final products of monoclonal antibodies, filgrastims, erythropoietins). The expert of the Feder
Externí odkaz:
https://doaj.org/article/d4c6eea1d8a54829bee19f0b97579524
Autor:
O. E. Kondratieva, M. E. Abramov, G. V. Vyshinskaya, S. L. Gutorov, E. I. Borisova, E. V. Cherniglazova
Publikováno v:
Медицинский совет, Vol 0, Iss 10, Pp 134-139 (2018)
Anemia is a common hematological complication in cancer patients receiving chemotherapy. Reduction of hemoglobin level is accompanied by a significant deterioration in the patients’ life quality. A transfusion of erythrocyte mass is used to rapidly
Externí odkaz:
https://doaj.org/article/d16d7184b8784ff5b0ed46ab1e009f7c
Autor:
O. A. GLADKOV, A. V. SNEGOVOY
Publikováno v:
Медицинский совет, Vol 0, Iss 10, Pp 44-46 (2016)
Anemia is one of the most frequent complications arising in patients with malignant growths, it is characterized by reduction of hemoglobin level and disturbance of a number of physiological and metabolic processes in the organism, impairing the cour
Externí odkaz:
https://doaj.org/article/b33cf0dd5fe94f3fa42d365b20d6b2bb
Autor:
A V Snegovoy
Publikováno v:
Современная онкология, Vol 15, Iss 2, Pp 65-72 (2013)
The continuing relevance of anemia in cancer patients is confirmed by the results of recent trials. Decreased hemoglobin levels are shown to lead to not only poorer quality of life, but also to lower survival rates in cancer patients. Today there is
Externí odkaz:
https://doaj.org/article/48941bfe20864395b590e3e979dba472
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Nana Uzovna Bekhorashvili, Maria Rayisyan, Rimma Yuiryevna Garankina, Elena Revovna Zakharochkina
Publikováno v:
Open Access Macedonian Journal of Medical Sciences; Vol. 8 No. E (2020): E-Public Health; 389-394
The study is aimed at identifying the key aspects of the national pharmacopeial regulation of the circulation of biotechnological medicines in the Russian pharmaceutical market and at studying the range of major groups based on the analysis of restri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0397d7a81fb8c2a10cc31a425b6b9f0b
https://doi.org/10.3889/oamjms.2020.3636
https://doi.org/10.3889/oamjms.2020.3636
Publikováno v:
Farmeconomia: Health Economics and Therapeutic Pathways, Vol 7, Iss 1, Pp 45-62 (2006)
Darbepoetin (DARB), a human erythropoietin with improved pharmacological parameters (longer half life and a dose-response relationship independent from the route of administration) is a new treatment option for chronic nephropathy-induced anemia that
Externí odkaz:
https://doaj.org/article/118a4b32aba64e44bf3726a7b33cabd4
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.